G protein-coupled receptor
5-HT6 receptor
5-hydroxytryptamine receptor 6
- GeneHTR6
- FamilySerotonin receptors
The 5-HT6 receptor is a serotonin receptor that was cloned from rat striatum in 1993, with a probe derived from the histamine H2 receptor. In transfected cells it is positively coupled to cAMP production. The human receptor was cloned in 1996 and likewise stimulates adenylyl cyclase.1,2 In the rat and the guinea pig, its messenger RNA is most abundant in serotonergic areas such as the striatum, olfactory tubercle, nucleus accumbens and hippocampus, with only faint expression in the rat stomach. In the human brain it is most prominent in the caudate nucleus, with lower amounts in the hippocampus and amygdala. In the rat brain, antibodies found the receptor protein in the olfactory tubercle, cerebral cortex, nucleus accumbens, striatum, hippocampus and cerebellum, and in the striatum and the dentate gyrus it was associated with dendrites. From its abundance in extrapyramidal and limbic areas, the authors suggested a role in the control of movement and of mood-dependent behaviour.1,2,3
In membranes of COS-7 cells that carried the human receptor, LSD bound with a KD of 3.16 nM and serotonin with a KD of 32.2 nM. The receptor has high affinity for several typical and atypical antipsychotics, including clozapine.2
Sources (3)
- Ruat et al. 1993Ruat M, Traiffort E, Arrang JM, et al. (1993) A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation Biochem Biophys Res Commun
- Kohen et al. 1996Kohen R, Metcalf MA, Khan N, et al. (1996) Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor J Neurochem
- Gérard et al. 1997Gérard C, Martres MP, Lefèvre K, et al. (1997) Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system Brain Res
Binding affinity (Kᵢ)
15 substances, 22 displayed values. Strongest first within each organism. The bar is pKᵢ on a log scale. Open a row to see the assay and every report behind the value.
Human
15 measurements
LSD16 nMJain et al. 2025 · 2 reports
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
- Range
- 4.4–16 nM in 2 reports
Sources and values behind the range, same assay family Report Value Where Jain et al. 2025 16 nM Table S4 Boess et al. 1998 4.4 nM Table 1 Bufotenin18 nMJain et al. 2025
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
ETH-LAD21 nMJain et al. 2025
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
5-MeO-DMT25 nMJain et al. 2025 · 3 reports
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
- Range
- 6.5–39 nM in 3 reports
Reported values disagree and no value is established. 4 reports in all, 6.5–39 nM.
Sources and values behind the range, same assay family Report Value Where Halberstadt et al. 2012 6.5 nM Table 1 Jain et al. 2025 25 nM Table S4 Glatfelter et al. 2024 39 nM Supplement Figure S1 Psilocin38 nMGlatfelter et al. 2022 · 2 reports
- Assay
- Transfected-cell radioligand binding at human 5-HT6 (UNC PDSP)
- Shown value from
- Glatfelter et al. 2022, Table 1
- Range
- 38–79 nM in 2 reports
Sources and values behind the range, same assay family Report Value Where Glatfelter et al. 2022 38 nM Table 1 Jain et al. 2025 79 nM Table S4 AL-LAD50 nMJain et al. 2025
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
4-HO-MET70 nMGlatfelter et al. 2023
- Assay
- human 5-HT6 receptor, [3H]LSD competition binding (NIMH PDSP)
- Shown value from
- Glatfelter et al. 2023, Table 2
Psilocybin89 nMGlatfelter et al. 2022 · 2 reports
- Assay
- Transfected-cell radioligand binding at human 5-HT6 (UNC PDSP)
- Shown value from
- Glatfelter et al. 2022, Table 1
- Range
- 89–780 nM in 2 reports
Reported values disagree and no value is established. 2 reports in all, 89–780 nM.
Sources and values behind the range, same assay family Report Value Where Glatfelter et al. 2022 89 nM Table 1 Jain et al. 2025 780 nM Table S4 DMT280 nMJain et al. 2025
- Assay
- radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
- Shown value from
- Jain et al. 2025, Table S4
5-MeO-MiPT281 nMGlatfelter et al. 2024
- Assay
- human 5-HT6 receptor, [3H]LSD competition binding
- Shown value from
- Glatfelter et al. 2024, Supplement Figure S1
DOI2254 nMGlatfelter et al. 2022
- Assay
- Transfected-cell radioligand binding at human 5-HT6 (UNC PDSP)
- Shown value from
- Glatfelter et al. 2022, Table 1
Pig
1 measurement
LSD5.3 nMBoess et al. 1998
- Assay
- porcine striatal membranes, [3H]Ro 63-0563 competition
- Shown value from
- Boess et al. 1998, Table 1
Rat
3 measurements
LSD17 nMBoess et al. 1997 · 2 reports
- Assay
- rat 5-HT6 receptor in HEK293 cells, [3H]5-HT competition
- Shown value from
- Boess et al. 1997, Table 1
- Range
- 6.3–17 nM in 2 reports
Sources and values behind the range, same assay family Report Value Where Boess et al. 1997 17 nM Table 1 Boess et al. 1998 6.3 nM Table 1 5-MeO-DMT79 nMBoess et al. 1994
- Assay
- cloned rat 5-ht6 receptor in COS-7 cells; [125I]LSD binding
- Shown value from
- Boess et al. 1994, Table 14
Bufotenin112 nMBoess et al. 1997 · 2 reports
- Assay
- rat 5-HT6 receptor in HEK293 cells, [3H]LSD competition
- Shown value from
- Boess et al. 1997, Table 1
- Range
- 4.5–112 nM in 2 reports
Values depend on the assay, species or conditions, and each is valid only for its own. 2 reports in all, 4.5–112 nM.
Unspecified
3 measurements
Psilocin57 nMDodd et al. 2023 · 2 reports
- Assay
- 5-HT6 binding, compiled in a review (Table 2), original assay not restated
- Shown value from
- Dodd et al. 2023, Table 2
Sources and values behind the range, same assay family Report Value Where Plazas et al. 2023 57 nM Table 5 Dodd et al. 2023 57 nM Table 2 Psilocybin414 nMPlazas et al. 2023
- Assay
- 5-HT6 receptor, compiled in a review table (Table 5), original assay not restated
- Shown value from
- Plazas et al. 2023, Table 5
DMT464 nMKeiser et al. 2009
- Assay
- NIMH PDSP radioligand competition binding at the 5-HT6 receptor, [3H]LSD (1.0 nM), standard binding buffer
- Shown value from
- Keiser et al. 2009, Supplementary Table 4
Functional potency (EC₅₀)
3 substances, 3 displayed values. Strongest first within each organism. Emax is shown where the paper reports it. Efficacy depends on the assay and its reference agonist.
Human
1 measurement
5-MeO-DMT0.24 nMCameron et al. 2021
- Assay
- human receptor in HEKT cells; cAMP GloSensor luminescence (Gs cAMP accumulation)
- Shown value from
- Cameron et al. 2021, Extended Data Fig. 5
- Emax
- 125.0%
Rat
2 measurements
LSD12 nMBoess et al. 1997
- Assay
- rat 5-HT6 receptor in HEK293 cells, cAMP accumulation
- Shown value from
- Boess et al. 1997, Table 2
- Emax
- 60.0%
Bufotenin46 nMBoess et al. 1997
- Assay
- rat 5-HT6 receptor in HEK293 cells, cAMP accumulation
- Shown value from
- Boess et al. 1997, Table 2
- Emax
- 107.0%
Values are published numbers in nM per organism. Different assays, species and receptor preparations are not directly interchangeable, and a value does not establish clinical potency or safety.